Core Viewpoint - North American Niobium and Critical Minerals Corp. is launching a fully-funded exploration program in 2026, focusing on its 29,936-hectare land package in Quebec, targeting niobium and rare earth elements to confirm and expand mineral resources [1][4][20]. Exploration Program Overview - The 2026 exploration program is structured in four stages: geophysics, surface geochemistry, bedrock sampling, and drilling, with a total budget of approximately $2.69 million [6][12][13]. - The drilling campaign will include 6,000 meters across multiple properties, with the largest allocation of $1.9 million dedicated to drilling costs [15][16]. Historical Assays and Comparisons - Historical assays from the company's properties show promising grades: 2.7% total rare earth oxides at Blanchette and 0.68% at Bardy, which are competitive with global producers [2][7]. - For niobium, the company's 0.32% Nb grab sample at Seigneurie is considered a strong early-stage indicator, aligning with grades from established niobium suppliers [3][4]. Importance of Niobium - Niobium is classified as a critical mineral by Canada and the U.S., essential for various high-tech applications, and its supply is heavily concentrated, raising national security concerns [18][19]. - Establishing a domestic source of niobium is crucial for North America's supply chain resilience, particularly for infrastructure and defense applications [18][19]. Quebec's Geological Potential - Quebec is recognized as a premier jurisdiction for critical mineral exploration, with significant geological potential and government support for mining activities [19][20]. - The Grenville Province is underexplored yet hosts major deposits, providing a favorable environment for advancing new discoveries in rare earth elements and niobium [19][20].

JUPITER, Fla. and WAGENINGEN, Netherlands, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and bioindustrial markets, and BRIG BIO (official legal entity The Protein Collective B.V.), a Netherlands-based developer of next-generation recombinant dairy ingredients, today announced the signing of a Development and Commercialization Agreement to jointly ...

TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) today provided an update on distributions. Through the sale of non-core assets in 2024 and 2025, Allied made progress in reducing the indebtedness it incurred to complete the last of its development projects, in several instances at full rather than partial ownership. The non-core sale process will continue in 2026. Through a series of successful bond offerings, Allied improved its debt profile o ...

HEDEHUSENE, Denmark, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ROCKWOOL products have long been known for their high quality and reliable performance in protecting the built environments where people live, learn, play, and recover. The new brand campaign puts these places and the people who live life in them every day at the forefront – where they belong. It's about protecting people, being resilient, and making a difference in people’s lives. And that is the spirit of the new tagline – that those who are worth eve ...

KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced an underwritten public offering of 5,500,000 common shares. Kestra is offering these shares pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (“SEC”). Kestra also intends to grant the underwriters a 30-day option to purchase up to an additional 825,000 common shares at the public offerin ...

The grocer is proud to support students across Ontario by providing nutritious breakfast kits while school is out.Toronto, ON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The holiday season is a time of joy and togetherness. For over 650,000 Ontario students, it also means losing access to the nutritious breakfast programs they rely on at school(1). This year, Metro is stepping in by distributing hand-packed breakfast kits to students across the province, because nutrition doesn’t go on holiday. In Canada, at least o ...

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and neurodegenerative diseases, today announced that Company executives will participate in a fireside chat at the upcoming Piper Sandler 37th Annual Healthcare Conference in New York. Piper Sandler 37th Annual Healthcare Conference details:Fireside ChatDate ...

KIRKLAND, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported preliminary financial results for the second quarter fiscal 2026 ended October 31, 2025. “Revenue is expected to grow by over 50% in the second quarter and continues to exceed our FY26 plan, reflecting sustained commercial momentum as Kestra grows and penetrates the wearable defibrillator market,” said Brian Webster, President and Chief ...

Cambridge, Massachusetts, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, will be participating in a fireside chat and investor one-on-one meetings at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2nd, 2025. The fireside chat will be hel ...

LONDON and GAITHERSBURG, Md., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced the appointment of Ryan Richardson to the Company’s Board of Directors. Mr. Richardson brings more than 20 years of strategy and corporate development experience and in the healthcare and investment banking industries to Autolus’ Board. “Autolus has ent ...